|
| | HB4313 Enrolled | | LRB102 21390 BMS 30506 b |
|
|
1 | | AN ACT concerning regulation.
|
2 | | Be it enacted by the People of the State of Illinois,
|
3 | | represented in the General Assembly:
|
4 | | Section 5. The Illinois Insurance Code is amended by |
5 | | changing Sections 131.22, 132.5, and 547 as follows:
|
6 | | (215 ILCS 5/131.22)
|
7 | | (Text of Section before amendment by P.A. 102-578 ) |
8 | | Sec. 131.22. Confidential treatment. |
9 | | (a) Documents, materials, or other information in the |
10 | | possession or control of the Department that are obtained by |
11 | | or disclosed to the Director or any other person in the course |
12 | | of an examination or investigation made pursuant to this |
13 | | Article and all information reported or provided to the |
14 | | Department pursuant to paragraphs (12) and (13) of Section |
15 | | 131.5 and Sections 131.13 through 131.21 shall be confidential |
16 | | by law and privileged, shall not be subject to the Illinois |
17 | | Freedom of Information Act, shall not be subject to subpoena, |
18 | | and shall not be subject to discovery or admissible in |
19 | | evidence in any private civil action. However, the Director is |
20 | | authorized to use the documents, materials, or other |
21 | | information in the furtherance of any regulatory or legal |
22 | | action brought as a part of the Director's official duties. |
23 | | The Director shall not otherwise make the documents, |
|
| | HB4313 Enrolled | - 2 - | LRB102 21390 BMS 30506 b |
|
|
1 | | materials, or other information public without the prior |
2 | | written consent of the company to which it pertains unless the |
3 | | Director, after giving the company and its affiliates who |
4 | | would be affected thereby prior written notice and an |
5 | | opportunity to be heard, determines that the interest of |
6 | | policyholders, shareholders, or the public shall be served by |
7 | | the publication thereof, in which event the Director may |
8 | | publish all or any part in such manner as may be deemed |
9 | | appropriate. |
10 | | (b) Neither the Director nor any person who received |
11 | | documents, materials, or other information while acting under |
12 | | the authority of the Director or with whom such documents, |
13 | | materials, or other information are shared pursuant to this |
14 | | Article shall be permitted or required to testify in any |
15 | | private civil action concerning any confidential documents, |
16 | | materials, or information subject to subsection (a) of this |
17 | | Section. |
18 | | (c) In order to assist in the performance of the |
19 | | Director's duties, the Director: |
20 | | (1) may share documents, materials, or other |
21 | | information, including the confidential and privileged |
22 | | documents, materials, or information subject to subsection |
23 | | (a) of this Section, with other state, federal, and |
24 | | international regulatory agencies, with the NAIC and its |
25 | | affiliates and subsidiaries, and with third-party
|
26 | | consultants, and with state, federal, and international |
|
| | HB4313 Enrolled | - 3 - | LRB102 21390 BMS 30506 b |
|
|
1 | | law enforcement authorities and regulatory agencies, |
2 | | including members of any supervisory college allowed by |
3 | | this Article, provided that the recipient agrees in |
4 | | writing to maintain the confidentiality and privileged |
5 | | status of the document, material, or other information, |
6 | | and has verified in writing the legal authority to |
7 | | maintain confidentiality; |
8 | | (1.5) notwithstanding paragraph (1) of this subsection |
9 | | (c), may only share confidential and privileged documents, |
10 | | material, or information reported pursuant to Section |
11 | | 131.14b with commissioners of states having statutes or |
12 | | regulations substantially similar to subsection (a) of |
13 | | this Section and who have agreed in writing not to |
14 | | disclose such information; and |
15 | | (1.7) notwithstanding paragraph (1) of this subsection |
16 | | (c), may only share confidential and privileged documents, |
17 | | material, or information reported pursuant to Section |
18 | | 131.14b with the Illinois Insurance Guaranty Fund |
19 | | regarding any member company defined in Section 534.5 if |
20 | | the member company has an authorized control level event |
21 | | as defined in Section 35A-25; the Director may disclose |
22 | | the information described in this subsection so long as |
23 | | the Fund agrees in writing to hold that information |
24 | | confidential, in a manner consistent with this Code, and |
25 | | uses that information to prepare for the possible |
26 | | liquidation of the member company; access to the |
|
| | HB4313 Enrolled | - 4 - | LRB102 21390 BMS 30506 b |
|
|
1 | | information disclosed by the Director to the Fund shall be |
2 | | limited to the Fund's staff and its counsel; the board of |
3 | | directors of the Fund may have access to the information |
4 | | disclosed by the Director to the Fund once the member |
5 | | company is subject to a delinquency proceeding under |
6 | | Article XIII subject to any terms and conditions |
7 | | established by the Director; and |
8 | | (2) may receive documents, materials, or information, |
9 | | including otherwise confidential and privileged documents, |
10 | | materials, or information from the NAIC and its affiliates |
11 | | and subsidiaries and from regulatory and law enforcement |
12 | | officials of other foreign or domestic jurisdictions, and |
13 | | shall maintain as confidential or privileged any document, |
14 | | material, or information received with notice or the |
15 | | understanding that it is confidential or privileged under |
16 | | the laws of the jurisdiction that is the source of the |
17 | | document, material, or information; any such documents,
|
18 | | materials, or information, while in the Director's |
19 | | possession, shall not be subject to the
Illinois Freedom |
20 | | of Information Act and shall not be subject to subpoena. |
21 | | (c-5) Written agreements with the NAIC or third-party |
22 | | consultants governing sharing and use of information provided |
23 | | pursuant to this Article consistent with this subsection (c) |
24 | | shall:
|
25 | | (1)
specify procedures and protocols regarding the |
26 | | confidentiality and security of information shared with |
|
| | HB4313 Enrolled | - 5 - | LRB102 21390 BMS 30506 b |
|
|
1 | | the NAIC and its affiliates and subsidiaries or |
2 | | third-party consultants pursuant to this Article, |
3 | | including procedures and protocols for sharing by the NAIC |
4 | | with other state, federal, or international regulators;
|
5 | | (2)
specify that ownership of information shared with |
6 | | the NAIC and its affiliates and subsidiaries or |
7 | | third-party consultants pursuant to this Article remains |
8 | | with the Director and the NAIC's or third-party |
9 | | consultant's use of the information is subject to the |
10 | | direction of the Director;
|
11 | | (3)
require prompt notice to be given to a company |
12 | | whose confidential information in the possession of the |
13 | | NAIC or third-party consultant pursuant to this Article is |
14 | | subject to a request or subpoena for disclosure or |
15 | | production; and
|
16 | | (4)
require the NAIC and its affiliates and |
17 | | subsidiaries or third-party consultants to consent to |
18 | | intervention by a company in any judicial or |
19 | | administrative action in which the NAIC and its affiliates |
20 | | and subsidiaries or third-party consultants may be |
21 | | required to disclose confidential information about the |
22 | | company shared with the NAIC and its affiliates and |
23 | | subsidiaries or third-party consultants pursuant to this |
24 | | Article. |
25 | | (d) The sharing of documents, materials, or information by |
26 | | the Director pursuant to this Article shall not constitute a |
|
| | HB4313 Enrolled | - 6 - | LRB102 21390 BMS 30506 b |
|
|
1 | | delegation of regulatory authority or rulemaking, and the |
2 | | Director is solely responsible for the administration, |
3 | | execution, and enforcement of the provisions of this Article. |
4 | | (e) No waiver of any applicable privilege or claim of |
5 | | confidentiality in the documents, materials, or information |
6 | | shall occur as a result of disclosure to the Director under |
7 | | this Section or as a result of sharing as authorized in |
8 | | subsection (c) of this Section. |
9 | | (f) Documents, materials, or other information in the |
10 | | possession or control of the NAIC or a third-party consultant |
11 | | pursuant to this Article shall be confidential by law and |
12 | | privileged, shall not be subject to the Illinois Freedom of |
13 | | Information Act, shall not be subject to subpoena, and shall |
14 | | not be subject to discovery or admissible in evidence in any |
15 | | private civil action.
|
16 | | (Source: P.A. 102-394, eff. 8-16-21.) |
17 | | (Text of Section after amendment by P.A. 102-578 )
|
18 | | Sec. 131.22. Confidential treatment. |
19 | | (a) Documents, materials, or other information in the |
20 | | possession or control of the Department that are obtained by |
21 | | or disclosed to the Director or any other person in the course |
22 | | of an examination or investigation made pursuant to this |
23 | | Article and all information reported or provided to the |
24 | | Department pursuant to paragraphs (12) and (13) of Section |
25 | | 131.5 and Sections 131.13 through 131.21 are recognized by |
|
| | HB4313 Enrolled | - 7 - | LRB102 21390 BMS 30506 b |
|
|
1 | | this State as being proprietary and to contain trade secrets, |
2 | | and shall be confidential by law and privileged, shall not be |
3 | | subject to the Illinois Freedom of Information Act, shall not |
4 | | be subject to subpoena, and shall not be subject to discovery |
5 | | or admissible in evidence in any private civil action. |
6 | | However, the Director is authorized to use the documents, |
7 | | materials, or other information in the furtherance of any |
8 | | regulatory or legal action brought as a part of the Director's |
9 | | official duties. The Director shall not otherwise make the |
10 | | documents, materials, or other information public without the |
11 | | prior written consent of the company to which it pertains |
12 | | unless the Director, after giving the company and its |
13 | | affiliates who would be affected thereby prior written notice |
14 | | and an opportunity to be heard, determines that the interest |
15 | | of policyholders, shareholders, or the public shall be served |
16 | | by the publication thereof, in which event the Director may |
17 | | publish all or any part in such manner as may be deemed |
18 | | appropriate. |
19 | | (b) Neither the Director nor any person who received |
20 | | documents, materials, or other information while acting under |
21 | | the authority of the Director or with whom such documents, |
22 | | materials, or other information are shared pursuant to this |
23 | | Article shall be permitted or required to testify in any |
24 | | private civil action concerning any confidential documents, |
25 | | materials, or information subject to subsection (a) of this |
26 | | Section. |
|
| | HB4313 Enrolled | - 8 - | LRB102 21390 BMS 30506 b |
|
|
1 | | (c) In order to assist in the performance of the |
2 | | Director's duties, the Director: |
3 | | (1) may share documents, materials, or other |
4 | | information, including the confidential and privileged |
5 | | documents, materials, or information subject to subsection |
6 | | (a) of this Section, including proprietary and trade |
7 | | secret documents and materials, with other state, federal, |
8 | | and international regulatory agencies, with the NAIC and |
9 | | its affiliates and subsidiaries, and with third-party
|
10 | | consultants, and with state, federal, and international |
11 | | law enforcement authorities and regulatory agencies, |
12 | | including members of any supervisory college allowed by |
13 | | this Article, provided that the recipient agrees in |
14 | | writing to maintain the confidentiality and privileged |
15 | | status of the document, material, or other information, |
16 | | and has verified in writing the legal authority to |
17 | | maintain confidentiality; |
18 | | (1.5) notwithstanding paragraph (1) of this subsection |
19 | | (c), may only share confidential and privileged documents, |
20 | | material, or information reported pursuant to subsection |
21 | | (a) of Section 131.14b with commissioners of states having |
22 | | statutes or regulations substantially similar to |
23 | | subsection (a) of this Section and who have agreed in |
24 | | writing not to disclose such information; and |
25 | | (1.7) notwithstanding paragraph (1) of this subsection |
26 | | (c), may only share confidential and privileged documents, |
|
| | HB4313 Enrolled | - 9 - | LRB102 21390 BMS 30506 b |
|
|
1 | | material, or information reported pursuant to Section |
2 | | 131.14b with the Illinois Insurance Guaranty Fund |
3 | | regarding any member company defined in Section 534.5 if |
4 | | the member company has an authorized control level event |
5 | | as defined in Section 35A-25; the Director may disclose |
6 | | the information described in this subsection so long as |
7 | | the Fund agrees in writing to hold that information |
8 | | confidential, in a manner consistent with this Code, and |
9 | | uses that information to prepare for the possible |
10 | | liquidation of the member company; access to the |
11 | | information disclosed by the Director to the Fund shall be |
12 | | limited to the Fund's staff and its counsel; the board of |
13 | | directors of the Fund may have access to the information |
14 | | disclosed by the Director to the Fund once the member |
15 | | company is subject to a delinquency proceeding under |
16 | | Article XIII subject to any terms and conditions |
17 | | established by the Director; and |
18 | | (2) may receive documents, materials, or information, |
19 | | including otherwise confidential and privileged documents, |
20 | | materials, or information, including proprietary and trade |
21 | | secret information, from the NAIC and its affiliates and |
22 | | subsidiaries and from regulatory and law enforcement |
23 | | officials of other foreign or domestic jurisdictions, and |
24 | | shall maintain as confidential or privileged any document, |
25 | | material, or information received with notice or the |
26 | | understanding that it is confidential or privileged under |
|
| | HB4313 Enrolled | - 10 - | LRB102 21390 BMS 30506 b |
|
|
1 | | the laws of the jurisdiction that is the source of the |
2 | | document, material, or information; any such documents,
|
3 | | materials, or information, while in the Director's |
4 | | possession, shall not be subject to the
Illinois Freedom |
5 | | of Information Act and shall not be subject to subpoena. |
6 | | (blank). |
7 | | (c-5) Written agreements with the NAIC or third-party |
8 | | consultants governing sharing and use of information provided |
9 | | pursuant to this Article consistent with subsection (c) shall:
|
10 | | (1)
specify procedures and protocols regarding the |
11 | | confidentiality and security of information shared with |
12 | | the NAIC and its affiliates and subsidiaries or |
13 | | third-party consultants pursuant to this Article, |
14 | | including procedures and protocols for sharing by the NAIC |
15 | | with other state, federal, or international regulators; |
16 | | the agreement shall provide that the recipient agrees in |
17 | | writing to maintain the confidentiality and privileged |
18 | | status of the documents, materials, or other information |
19 | | and has verified in writing the legal authority to |
20 | | maintain such confidentiality;
|
21 | | (2)
specify that ownership of information shared with |
22 | | the NAIC and its affiliates and subsidiaries or |
23 | | third-party consultants pursuant to this Article remains |
24 | | with the Director and the NAIC's or third-party |
25 | | consultant's use of the information is subject to the |
26 | | direction of the Director;
|
|
| | HB4313 Enrolled | - 11 - | LRB102 21390 BMS 30506 b |
|
|
1 | | (3)
require prompt notice to be given to a company |
2 | | whose confidential information in the possession of the |
3 | | NAIC or third-party consultant pursuant to this Article is |
4 | | subject to a request or subpoena for disclosure or |
5 | | production;
|
6 | | (4)
require the NAIC and its affiliates and |
7 | | subsidiaries or third-party consultants to consent to |
8 | | intervention by a company in any judicial or |
9 | | administrative action in which the NAIC and its affiliates |
10 | | and subsidiaries or third-party consultants may be |
11 | | required to disclose confidential information about the |
12 | | company shared with the NAIC and its affiliates and |
13 | | subsidiaries or third-party consultants pursuant to this |
14 | | Article; and |
15 | | (5) excluding documents, material, or information |
16 | | reported pursuant to subsection (c) of Section 131.14b, |
17 | | prohibit the NAIC or third-party consultant from storing |
18 | | the information shared pursuant to this Code in a |
19 | | permanent database after the underlying analysis is |
20 | | completed. |
21 | | (d) The sharing of documents, materials, or information by |
22 | | the Director pursuant to this Article shall not constitute a |
23 | | delegation of regulatory authority or rulemaking, and the |
24 | | Director is solely responsible for the administration, |
25 | | execution, and enforcement of the provisions of this Article. |
26 | | (e) No waiver of any applicable privilege or claim of |
|
| | HB4313 Enrolled | - 12 - | LRB102 21390 BMS 30506 b |
|
|
1 | | confidentiality in the documents, materials, or information |
2 | | shall occur as a result of disclosure to the Director under |
3 | | this Section or as a result of sharing as authorized in |
4 | | subsection (c) of this Section. |
5 | | (f) Documents, materials, or other information in the |
6 | | possession or control of the NAIC or third-party consultant |
7 | | pursuant to this Article shall be confidential by law and |
8 | | privileged, shall not be subject to the Illinois Freedom of |
9 | | Information Act, shall not be subject to subpoena, and shall |
10 | | not be subject to discovery or admissible in evidence in any |
11 | | private civil action.
|
12 | | (Source: P.A. 102-394, eff. 8-16-21; 102-578, eff. 12-31-22; |
13 | | revised 9-22-21.)
|
14 | | (215 ILCS 5/132.5) (from Ch. 73, par. 744.5)
|
15 | | Sec. 132.5. Examination reports.
|
16 | | (a) General description. All examination reports shall be |
17 | | comprised of
only facts appearing upon the books, records, or |
18 | | other documents of the
company, its agents, or other persons |
19 | | examined or as ascertained from the
testimony of its officers, |
20 | | agents, or other persons examined concerning its
affairs and |
21 | | the conclusions and recommendations as the examiners find
|
22 | | reasonably warranted from those facts.
|
23 | | (b) Filing of examination report. No later than 60 days |
24 | | following
completion of the examination, the examiner in |
25 | | charge shall file with the
Department a verified written |
|
| | HB4313 Enrolled | - 13 - | LRB102 21390 BMS 30506 b |
|
|
1 | | report of examination under oath. Upon
receipt of the verified |
2 | | report, the Department shall transmit the report to
the |
3 | | company examined, together with a notice that affords the |
4 | | company examined
a reasonable opportunity of not more than 30 |
5 | | days to make a written
submission or rebuttal with respect to |
6 | | any matters contained in the examination report.
|
7 | | (c) Adoption of the report on examination. Within 30 days |
8 | | of the end of the
period allowed for the receipt of written |
9 | | submissions or rebuttals, the
Director shall fully consider |
10 | | and review the report, together with any
written submissions |
11 | | or rebuttals and any relevant portions of the examiners
work |
12 | | papers and enter an order:
|
13 | | (1) Adopting the examination report as filed or with |
14 | | modification or
corrections. If the examination report |
15 | | reveals that the company is
operating in violation of any |
16 | | law, regulation, or prior order of the
Director, the |
17 | | Director may order the company to take any action the
|
18 | | Director considers necessary and appropriate to cure the |
19 | | violation.
|
20 | | (2) Rejecting the examination report with directions |
21 | | to the examiners
to reopen the examination for purposes of |
22 | | obtaining additional data,
documentation, or information |
23 | | and refiling under subsection (b).
|
24 | | (3) Calling for an investigatory hearing with no less |
25 | | than 20 days
notice to the company for purposes of |
26 | | obtaining additional documentation,
data, information, and |
|
| | HB4313 Enrolled | - 14 - | LRB102 21390 BMS 30506 b |
|
|
1 | | testimony.
|
2 | | (d) Order and procedures. All orders entered under |
3 | | paragraph (1) of
subsection (c) shall be accompanied by |
4 | | findings and conclusions resulting
from the Director's |
5 | | consideration and review of the examination report,
relevant |
6 | | examiner work papers, and any written submissions or |
7 | | rebuttals.
The order shall be considered a final |
8 | | administrative decision and may be
appealed in accordance with |
9 | | the Administrative Review Law. The order shall
be served upon |
10 | | the company by certified mail, together with a copy of the
|
11 | | adopted examination report. Within 30 days of the issuance of |
12 | | the adopted
report, the company shall file affidavits executed |
13 | | by each of its directors
stating under oath that they have |
14 | | received a copy of the adopted report and
related orders.
|
15 | | Any hearing conducted under paragraph (3) of subsection |
16 | | (c) by the
Director or an authorized representative shall be |
17 | | conducted as a
nonadversarial confidential investigatory |
18 | | proceeding as necessary for the
resolution of any |
19 | | inconsistencies, discrepancies, or disputed issues
apparent |
20 | | upon the face of the filed examination report or raised by or |
21 | | as a
result of the Director's review of relevant work papers or |
22 | | by the written
submission or rebuttal of the company.
Within |
23 | | 20 days of the conclusion of any hearing, the Director shall |
24 | | enter
an order under paragraph (1) of subsection (c).
|
25 | | The Director shall not appoint an examiner as an |
26 | | authorized
representative to conduct the hearing. The hearing |
|
| | HB4313 Enrolled | - 15 - | LRB102 21390 BMS 30506 b |
|
|
1 | | shall proceed
expeditiously with discovery by the company |
2 | | limited to the examiner's work
papers that tend to |
3 | | substantiate any assertions set forth in any written
|
4 | | submission or rebuttal. The Director or his representative may |
5 | | issue
subpoenas for the attendance of any witnesses or the |
6 | | production of any
documents deemed relevant to the |
7 | | investigation, whether under the control
of the Department, |
8 | | the company, or other persons. The documents produced
shall be |
9 | | included in the record, and testimony taken by the Director or |
10 | | his
representative shall be under oath and preserved for the |
11 | | record. Nothing
contained in this Section shall require the |
12 | | Department to disclose any
information or records that would |
13 | | indicate or show the existence or content
of any investigation |
14 | | or activity of a criminal justice agency.
|
15 | | The hearing shall proceed with the Director or his |
16 | | representative
posing questions to the persons subpoenaed. |
17 | | Thereafter the company and the
Department may present |
18 | | testimony relevant to the investigation.
Cross-examination |
19 | | shall be conducted only by the Director or his representative.
|
20 | | The company and the Department shall be permitted to make |
21 | | closing
statements and may be represented by counsel of their |
22 | | choice.
|
23 | | (e) Publication and use. Upon the adoption of the |
24 | | examination report
under paragraph (1) of subsection (c), the |
25 | | Director shall continue to hold
the content of the examination |
26 | | report as private and confidential
information for a period of |
|
| | HB4313 Enrolled | - 16 - | LRB102 21390 BMS 30506 b |
|
|
1 | | 35 days, except to the extent provided in
subsection (b). |
2 | | Thereafter, the Director may open the report for public
|
3 | | inspection so long as no court of competent jurisdiction has |
4 | | stayed its publication.
|
5 | | Nothing contained in this Code shall prevent or be |
6 | | construed as
prohibiting the Director from disclosing the |
7 | | content of an examination
report, preliminary examination |
8 | | report or results, or any matter relating
thereto, to the |
9 | | insurance department of any other state or country or to law
|
10 | | enforcement officials of this or any other state or agency of |
11 | | the federal
government at any time, so long as the agency or |
12 | | office receiving the
report or matters relating thereto agrees |
13 | | in writing to hold it
confidential and in a manner consistent |
14 | | with this Code.
|
15 | | In the event the Director determines that regulatory |
16 | | action is
appropriate as a result of any examination, he may |
17 | | initiate any
proceedings or actions as provided by law.
|
18 | | (f) Confidentiality of ancillary information. All working |
19 | | papers,
recorded information, documents, and copies
thereof |
20 | | produced by, obtained by, or disclosed to the Director or any |
21 | | other
person in the course of any examination must be given |
22 | | confidential
treatment, are not subject to subpoena, and may |
23 | | not be made public by the
Director or any other persons, except |
24 | | to the extent provided in subsection
(e). Access may also be |
25 | | granted to the National Association of Insurance |
26 | | Commissioners.
Those parties must agree in writing before |
|
| | HB4313 Enrolled | - 17 - | LRB102 21390 BMS 30506 b |
|
|
1 | | receiving the information to
provide to it the same |
2 | | confidential treatment as required by this Section,
unless the |
3 | | prior written consent of the company to which it pertains has |
4 | | been obtained.
|
5 | | This subsection (f) applies to market conduct examinations |
6 | | described in Section 132 of this Code. |
7 | | (g) Disclosure. Nothing contained in this Code shall |
8 | | prevent or be construed as prohibiting the Director from |
9 | | disclosing the information described in subsections (e) and |
10 | | (f) to the Illinois Insurance Guaranty Fund regarding any |
11 | | member company defined in Section 534.5 if the member company |
12 | | has an authorized control level event as defined in Section |
13 | | 35A-25. The Director may disclose the information described in |
14 | | this subsection so long as the Fund agrees in writing to hold |
15 | | that information confidential, in a manner consistent with |
16 | | this Code, and uses that information to prepare for the |
17 | | possible liquidation of the member company. Access to the |
18 | | information disclosed by the Director to the Fund shall be |
19 | | limited to the Fund's staff and its counsel. The Board of |
20 | | Directors of the Fund may have access to the information |
21 | | disclosed by the Director to the Fund once the member company |
22 | | is subject to a delinquency proceeding under Article XIII |
23 | | subject to any terms and conditions established by the |
24 | | Director. |
25 | | (Source: P.A. 100-475, eff. 1-1-18 .)
|
|
| | HB4313 Enrolled | - 18 - | LRB102 21390 BMS 30506 b |
|
|
1 | | (215 ILCS 5/547) (from Ch. 73, par. 1065.97)
|
2 | | Sec. 547. Prevention of insolvencies. To aid in the |
3 | | detection and prevention of company insolvencies:
|
4 | | (a) The board of directors may, upon majority vote, make |
5 | | recommendations
to the Director on matters pertaining to |
6 | | regulation for solvency.
|
7 | | (b) The board of directors may prepare a report on the |
8 | | history and causes
of any company
insolvency in which the Fund |
9 | | was obligated to pay covered claims, based on the
information |
10 | | available to the Fund, and submit such report to the Director.
|
11 | | (c) The Director may disclose to the Fund the information |
12 | | described in subsection (g) of Section 132.5 as well as the |
13 | | information described in subsection (c) of Section 131.22, and |
14 | | the Fund may use that information to prepare for the possible |
15 | | liquidation of a member company subject to the requirements |
16 | | and restrictions set forth in Section 132.5. |
17 | | (Source: P.A. 85-576.)
|
18 | | Section 95. No acceleration or delay. Where this Act makes |
19 | | changes in a statute that is represented in this Act by text |
20 | | that is not yet or no longer in effect (for example, a Section |
21 | | represented by multiple versions), the use of that text does |
22 | | not accelerate or delay the taking effect of (i) the changes |
23 | | made by this Act or (ii) provisions derived from any other |
24 | | Public Act.
|
25 | | Section 99. Effective date. This Act takes effect upon |